Move For Interlocutory Appeal Denied In Reglan Case
Generics makers including Teva Pharmaceuticals USA Inc. and Barr Pharmaceuticals LLC have lost their bid for an interlocutory appeal of a ruling denying their motions for summary judgment in a failure-to-warn...To view the full article, register now.
Already a subscriber? Click here to view full article